Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

C225 shows absence of dose-limiting toxicity

May 31, 1996

ALRT-1057 exhibits high incidence of complete remission

May 31, 1996

U.S. Bioscience and Alza embark on marketing agreement for altretamine

May 31, 1996

Ligand reveals RXR-selective retinoid

May 31, 1996

MF-13 revealed as a selective tumor apoptosis-inducing agent

May 31, 1996

NSC-652287D shows important antitumor activity

May 31, 1996

Dainippon reveals compounds with antitumor activity

May 31, 1996

Spicamycin derivative revealed

May 31, 1996

Otsuka reveals matrix metalloproteinase inhibitors

May 31, 1996

Ciba-Geigy describes CGP-59326, a powerful antitumor agent

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 12, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 12, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.